Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-19

Clinical Trial Update: A Study to Assess the Systemic Exposure of FLIXOTIDE™ (Fluticasone Propionate) and SERETIDE™ (Fluticasone Propionate and Salmeterol) Given With VENTOLIN™ Mini-Spacer Compared to the Aerochamber Plus Spacer [Phase 1]

View source ↗

Summary

Phase 1 study assessing systemic exposure of Fluticasone Propionate (alone and in combination with Salmeterol) when delivered with Ventolin Mini-Spacer versus A…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FLIXOTIDE (Fluticasone Propionate)
  • Seretide (fluticasone propionate/salmeterol)
  • Ventolin (albuterol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED